We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VMI:NYSEValmont Industries, Inc. Analysis

Data as of 2026-06-10 - not real-time

$512.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Valmont Industries is trading at $512.25, comfortably above its 50‑day SMA of 485.00 and 200‑day SMA of 431.48, but slightly under the 20‑day SMA of 521.31, suggesting short‑term price pressure. The stock sits near a technical support zone at 485.29 with resistance around 548.90, while volume has been trending upward and the 30‑day volatility is elevated at 27.5%, reflecting a fairly active market. Momentum indicators are mixed: the RSI of 48.8 points to a neutral stance, yet the MACD histogram is negative (-2.75) and the signal line signals bearishness, tempering the bullish trend label. On the fundamentals side, VMI posted $4.16 B in revenue with a 6.2% growth rate, and its forward EPS of 25.45 implies a forward P/E of 20.1, a notable improvement over the trailing P/E of 28.5. Margins remain solid (gross 30.4%, operating 15.0%) and cash flow is healthy, supporting a modest dividend yield of 0.54% with a low payout ratio of 15.6%. However, the DCF‑derived fair value of $124.94 suggests the market price is significantly overvalued, a view reinforced by a beta of 1.28 and a max drawdown of nearly 20%. Analyst consensus is a “Buy” with a mean target of $545.25, indicating expectations for upside limited to roughly 6% above current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with increasing volume
  • Bearish MACD histogram offset by bullish trend direction
  • Neutral RSI indicating limited near‑term upside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improving forward earnings and lower forward P/E
  • Steady revenue growth and solid operating margins
  • Analyst consensus and modest upside potential

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Exposure to infrastructure and renewable‑energy markets
  • Significant valuation gap relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth6.20%
Profit Margin8.91%
P/E Ratio28.5
ROE22.19%
ROA10.08%
Debt/Equity54.96
P/B Ratio6.1
Op. Cash Flow$494.8M
Free Cash Flow$187.2M
Industry P/E29.5

Technical Analysis

TrendBullish
RSI48.8
Support$485.29
Resistance$548.90
MA 20$521.31
MA 50$485.00
MA 200$431.48
MACDBearish
VolumeIncreasing
Fear & Greed Index81.75

Valuation

Fair Value$124.94
Target Price$545.25
Upside/Downside6.44%
GradeOvervalued
TypeGrowth
Dividend Yield0.54%

Risk Assessment

Beta1.28
Volatility27.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.